XORTX Therapeutics Inc. Share Price
NASDAQ: XRTXXORTX Therapeutics Inc. Stock Performance
XORTX Therapeutics Inc. Share Price Today
As of 30 October 2026, XORTX Therapeutics Inc.'s share price is $1.09. The stock opened at $1.08, compared to its previous close of $1.08. During today's trading session, XORTX Therapeutics Inc.'s share price traded between $1.06 and $1.08, with an average price of $1.07. Over the past 52 weeks, the stock has recorded a high of $3.57 and a low of $0.36. In terms of performance, XORTX Therapeutics Inc.'s share price has declined by 62.28% over the last six months and is up 78.98% on a year-on-year basis.
XORTX Therapeutics Inc. Share Price Chart
XORTX Therapeutics Inc. Annual Profit & Loss
All figures in USD
About XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.
XORTX Therapeutics Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.75 | $1.06 | -38.01% |
Sep 2026 | $2.27 | $1.71 | -16.59% |
Aug 2026 | $2.12 | $2.05 | -1.68% |
Jul 2026 | $2.16 | $2.08 | -6.08% |
Jun 2026 | $2.22 | $2.22 | -2.42% |
May 2026 | $2.70 | $2.27 | -21.28% |
Apr 2026 | $0.46 | $2.89 | +658.53% |
Mar 2026 | $0.39 | $0.38 | -6.85% |
Feb 2026 | $0.52 | $0.41 | -19.80% |
Jan 2026 | $0.59 | $0.51 | -17.07% |
Dec 2025 | $0.63 | $0.61 | -6.11% |
Nov 2025 | $0.62 | $0.66 | +7.55% |